Skip to main content
OpenTrials

Clinical trial condition

Breast Cancer

Explore clinical trials studying Breast Cancer. Study availability and eligibility vary by location and protocol.

6,461 public trials 1,143 recruiting studies
Refine in advanced search Browse all conditions

Breast Cancer trial results

Active, Not Recruiting

A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors

NCT05787587

Conditions
Adnexal Diseases, Advanced or Metastatic Solid Tumors, Breast Cancer, +44 more
Locations
  • HonorHealth Research Institute Phoenix, Arizona, United States
  • The Angeles Clinic Los Angeles, California, United States
  • Hoag Memorial Hospital Newport Beach, California, United States
  • California Pacific Medical Center San Francisco, California, United States
View all 27 locations
View Trial Details
Active, Not Recruiting

Tucatinib+Trastuzumab+Eribulin in HER2+ MBC

NCT05458674

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • University of Colorado Aurora, Colorado, United States
  • George Washington Medical Faculty Associates Washington D.C., District of Columbia, United States
  • New Mexico Cancer Care Alliance Albuquerque, New Mexico, United States
  • Swedish Cancer Institute Issaquah, Washington, United States
View Trial Details
Active, Not Recruiting

Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases

NCT04711824

Conditions
Brain Diseases, Brain Metastases, Adult, Brain Neoplasms, +11 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Memorial Healthcare System Hollywood, Florida, United States
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Active, Not Recruiting

Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab [IIT2018-04-MCARTHUR-NEOHP]

NCT03747120

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • New Mexico Cancer Center Albuquerque, New Mexico, United States
  • Providence Cancer Institute Portland, Oregon, United States
View Trial Details
Active, Not Recruiting

DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE)

NCT04567420

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
View all 19 locations
View Trial Details

Related conditions